Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease.
Savarino E, Gemignani L, Pohl D, Zentilin P, Dulbecco P, Assandri L, Marabotto E, Bonfanti D, Inferrera S, Fazio V, Malesci A, Tutuian R, Savarino V. Savarino E, et al. Among authors: gemignani l. Aliment Pharmacol Ther. 2011 Aug;34(4):476-86. doi: 10.1111/j.1365-2036.2011.04742.x. Epub 2011 Jun 14. Aliment Pharmacol Ther. 2011. PMID: 21671968 Free article.
Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy.
Savarino E, Tutuian R, Zentilin P, Dulbecco P, Pohl D, Marabotto E, Parodi A, Sammito G, Gemignani L, Bodini G, Savarino V. Savarino E, et al. Among authors: gemignani l. Am J Gastroenterol. 2010 May;105(5):1053-61. doi: 10.1038/ajg.2009.670. Epub 2009 Dec 8. Am J Gastroenterol. 2010. PMID: 19997095
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth.
Furnari M, Parodi A, Gemignani L, Giannini EG, Marenco S, Savarino E, Assandri L, Fazio V, Bonfanti D, Inferrera S, Savarino V. Furnari M, et al. Among authors: gemignani l. Aliment Pharmacol Ther. 2010 Oct;32(8):1000-6. doi: 10.1111/j.1365-2036.2010.04436.x. Epub 2010 Aug 18. Aliment Pharmacol Ther. 2010. PMID: 20937045 Free article. Clinical Trial.
Achalasia with dense eosinophilic infiltrate responds to steroid therapy.
Savarino E, Gemignani L, Zentilin P, De Bortoli N, Malesci A, Mastracci L, Fiocca R, Savarino V. Savarino E, et al. Among authors: gemignani l. Clin Gastroenterol Hepatol. 2011 Dec;9(12):1104-6. doi: 10.1016/j.cgh.2011.08.002. Epub 2011 Aug 11. Clin Gastroenterol Hepatol. 2011. PMID: 21839711
Overweight is a risk factor for both erosive and non-erosive reflux disease.
Savarino E, Zentilin P, Marabotto E, Bonfanti D, Inferrera S, Assandri L, Sammito G, Gemignani L, Furnari M, Dulbecco P, Savarino V. Savarino E, et al. Among authors: gemignani l. Dig Liver Dis. 2011 Dec;43(12):940-5. doi: 10.1016/j.dld.2011.07.014. Epub 2011 Sep 22. Dig Liver Dis. 2011. PMID: 21944835
18 results